Westside Investment Management, Inc. Unity Biotechnology, Inc. Transaction History

Westside Investment Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Jul 21, 2020	SELL	$5.28 - $9.67 $528 - $967	-100 Reduced 50.0%	100 $0
Q2 2019 Jul 24, 2019	BUY	$7.59 - $10.21 $1,518 - $2,042	200 New	200 $1,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Westside Investment Management, Inc. with notifications on news.